Month: March 2026

LONDON, March 11, 2026 (GLOBE NEWSWIRE) — RedCloud Holdings plc (NASDAQ: RCT) (“RedCloud” or the “Company”), the technology company building AI infrastructure for global trade, today announced the appointment of Raju Datla as Chief Financial Officer, strengthening the Company’s leadership team as it enters its next phase of commercial scale and capital markets development. A current member of RedCloud’s executive leadership team, Datla previously served as Chief Strategy Officer, where he played a central role in shaping the Company’s long-term growth roadmap, capital strategy and market expansion plans. His appointment ensures leadership continuity while aligning financial stewardship directly with RedCloud’s strategic execution priorities. Datla brings deep experience across digital infrastructure, capital...

LONG BEACH, Calif., March 11, 2026 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) (the “Company”) announced today that, subject to market and other conditions, it intends to offer and sell to eligible purchasers $250 million in aggregate principal amount of its 7.000% senior unsecured notes due 2034 (the “Notes”). The Notes are being offered as additional notes under the indenture dated as of October 8, 2025, as may be supplemented from time to time (the “Indenture”), pursuant to which the Company previously issued $400 million aggregate principal amount of 7.000% Senior Notes (the “Existing Notes”). The Notes will have substantially identical terms, other than the issue date and issue price, as the Existing Notes, and the Notes and the Existing Notes will be treated as a single series of securities under the Indenture...

RAPALA VMC CORPORATION, Other information disclosed according to the rules of the Exchange, March 11, 2026 at 3:30 p.m. EET RAPALA VMC CORPORATION RESOLVED ON NEW PERFORMANCE PERIOD 2026—2028 FOR THE COMPANY’S PERFORMANCE SHARE PLAN  The Board of Directors of Rapala VMC Corporation established a Performance Share Plan 2025-2029 for the company’s key employees in 2025. Performance Share Plan 2025-2029 includes three performance periods, covering the calendar years 2025—2027, 2026—2028 and 2027–2029. The key terms of the Performance Share Plan 2025–2029 were published by stock exchange release on 23 July 2025.  The Board of Directors of Rapala VMC has resolved on the target group, the amount of the possible rewards and the performance criteria for the performance period 2026—2028.  For the performance period 2026—2028 the plan’s target group...

CSA Score of 93 Sets New Industry RecordE Ink Tops S&P Global Sustainability Yearbook RankingsE Ink recognized as a Global Top 1% company in the S&P Global Sustainability Yearbook 2026BILLERICA, Mass., March 11, 2026 (GLOBE NEWSWIRE) — E Ink (8069.TW), the global leader in ePaper technology, announced that it has been recognized as a Global Top 1% company in the S&P Global Sustainability Yearbook 2026. In the Electronic Equipment, Instruments & Components industry category, E Ink achieved a Corporate Sustainability Assessment (CSA) score of 93, marking the second consecutive year it has earned—and surpassed—the highest score in the global industry. The S&P Global Sustainability Yearbook evaluates over 9,200 companies across 59 industries worldwide and selects top-performing companies based on CSA...

3nm 400G/lane technology enables best-in-class 1.6T transceivers and lays the foundation for 204.8T networks using 3.2T transceivers PALO ALTO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced the availability of its 3nm 400G/lane optical PAM-4 DSP, the Taurus™ BCM83640, optimized for 1.6T transceiver solutions with unprecedented bandwidth density and efficiency. The device features 400G/lane serial optical interfaces, which enable optical transceiver manufacturers to cost effectively deliver low power 1.6T pluggable modules to meet the growing bandwidth needs for AI data centers. Taurus™ BCM83640 Product HighlightsMonolithic 3nm 1.6T (8:4) PAM-4 DSP with integrated...

Access the Moleculin CEO Corner here HOUSTON, March 11, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has released the next segment on its CEO Corner, a platform featuring Walter Klemp, Chief Executive Officer. The CEO Corner is designed to provide investors and stakeholders with enhanced insight into the Company’s corporate developments, clinical progress and strategic initiatives. As part of the segment, Mr. Klemp discussed progress on the Company’s pivotal MIRACLE Study evaluating Annamycin in combination with cytarabine (AnnAraC) for patients with relapsed or refractory Acute Myeloid Leukemia. Mr. Klemp explained that the adaptive Phase 3 trial was designed with input from the U.S. Food and Drug Administration and includes an initial cohort of 45 patients....

SKYX is Expected to Supply 10,000 of its Advanced Technologies to the New Pittsford Oaks Apartment Development in Pittsford, New York The Development will include 171 Apartments with Top-of-the-Line Amenities including an In-House Clubhouse, Fitness Center, Erie Canal Trail Access, and Underground Garage Heated Parking SKYX’s Technologies Expansion Provides Additional Opportunities for Future Recurring Revenues through Interchangeability, Upgrades, AI Services, Monitoring, Subscriptions, Among Others MIAMI, March 11, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive smart home platform technology company with over 100 pending and issued patents globally and 60 lighting and home décor websites, with a mission to make homes and buildings become safe...

“The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today reinforced how its strategic investment in PsyLabs strengthens its control over pharmaceutical-grade manufacturing and commercial supply chain infrastructure – a critical differentiator in the rapidly expanding psychedelic pharmaceutical sector. Through its investment in PsyLabs, Psyence BioMed has secured:A licensed, owned, and debt-free production operation. Source-level ibogaine supply. Natural psilocybin supply. GMP-compliant manufacturing capabilities. Intellectual property protection. Integrated analytical and chemistry laboratory infrastructure. A capital structure with no corporate...